Literature DB >> 34376486

Reproducibility, Temporal Variability, and Concordance of Serum and Fecal Bile Acids and Short Chain Fatty Acids in a Population-Based Study.

Zeinab Farhat1, Joshua N Sampson2, Allan Hildesheim3, Mahboobeh Safaeian4, Carolina Porras5, Bernal Cortés5, Rolando Herrero5, Byron Romero5, Emily Vogtmann6, Rashmi Sinha6, Erikka Loftfield6.   

Abstract

BACKGROUND: Bile acid (BA) and short chain fatty acid (SCFA) production is affected by diet and microbial metabolism. These metabolites may play important roles in human carcinogenesis.
METHODS: We used a fully quantitative targeted LC-MS/MS system to measure serum and fecal BA and SCFA concentrations in 136 Costa Rican adults at study baseline and 6-months. We randomly selected 50 participants and measured their baseline samples in duplicate. Our objective was to evaluate: Technical reproducibility; 6-month temporal variability; and concordance between sample type collected from the same individual at approximately the same time.
RESULTS: Technical reproducibility was excellent, with intraclass correlation coefficients (ICC) ≥0.83 for all BAs except serum tauroursodeoxycholic acid (ICC = 0.72) and fecal glycolithocholic acid (ICC = 0.66) and ICCs ≥0.81 for all SCFAs except serum 2-methylbutyric acid (ICC = 0.56) and serum isobutyric acid (ICC = 0.64). Temporal variability ICCs were generally low, but several BAs (i.e., deoxycholic, glycoursodeoxycholic, lithocholic, taurocholic, and tauroursodeoxycholic acid) and SCFAs (i.e., 2-methylbutyric, butyric, propionic, and valeric acid) had 6-month ICCs ≥0.44. The highest degree of concordance was observed for secondary and tertiary BAs.
CONCLUSIONS: Serum and fecal BAs and SCFAs were reproducibly measured. However, 6-month ICCs were generally low, indicating that serial biospecimen collections would increase statistical power in etiologic studies. The low concordance for most serum and fecal metabolites suggests that consideration should be paid to treating these as proxies. IMPACT: Our findings will inform the design and interpretation of future human studies on associations of BAs, SCFAs, and potentially other microbial metabolites, with disease risk. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34376486      PMCID: PMC8608567          DOI: 10.1158/1055-9965.EPI-21-0361

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  48 in total

1.  Colonic mucosal proliferation is related to serum deoxycholic acid levels.

Authors:  T Ochsenkühn; E Bayerdörffer; A Meining; M Schinkel; C Thiede; V Nüssler; M Sackmann; R Hatz; A Neubauer; G Paumgartner
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.

Authors:  Alexander Kurilshikov; Inge C L van den Munckhof; Lianmin Chen; Marc J Bonder; Kiki Schraa; Joost H W Rutten; Niels P Riksen; Jacqueline de Graaf; Marije Oosting; Serena Sanna; Leo A B Joosten; Marinette van der Graaf; Tessa Brand; Debby P Y Koonen; Martijn van Faassen; P Eline Slagboom; Ramnik J Xavier; Folkert Kuipers; Marten H Hofker; Cisca Wijmenga; Mihai G Netea; Alexandra Zhernakova; Jingyuan Fu
Journal:  Circ Res       Date:  2019-04-11       Impact factor: 17.367

3.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

Authors:  Henri Duboc; Sylvie Rajca; Dominique Rainteau; David Benarous; Marie-Anne Maubert; Elodie Quervain; Ginette Thomas; Véronique Barbu; Lydie Humbert; Guillaume Despras; Chantal Bridonneau; Fabien Dumetz; Jean-Pierre Grill; Joëlle Masliah; Laurent Beaugerie; Jacques Cosnes; Olivier Chazouillères; Raoul Poupon; Claude Wolf; Jean-Maurice Mallet; Philippe Langella; Germain Trugnan; Harry Sokol; Philippe Seksik
Journal:  Gut       Date:  2012-09-19       Impact factor: 23.059

4.  Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats.

Authors:  T Hori; K Matsumoto; Y Sakaitani; M Sato; M Morotomi
Journal:  Cancer Lett       Date:  1998-02-13       Impact factor: 8.679

5.  Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon.

Authors:  Janet A Vogt; Thomas M S Wolever
Journal:  J Nutr       Date:  2003-10       Impact factor: 4.798

Review 6.  Short chain fatty acids and colonic health.

Authors:  E Hijova; A Chmelarova
Journal:  Bratisl Lek Listy       Date:  2007       Impact factor: 1.278

Review 7.  Review article: the role of butyrate on colonic function.

Authors:  H M Hamer; D Jonkers; K Venema; S Vanhoutvin; F J Troost; R-J Brummer
Journal:  Aliment Pharmacol Ther       Date:  2007-10-25       Impact factor: 8.171

8.  Faecal bile-acids and clostridia in patients with cancer of the large bowel.

Authors:  M J Hill; B S Drasar; R E Williams; T W Meade; A G Cox; J E Simpson; B C Morson
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

9.  Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.

Authors:  E Bayerdörffer; G A Mannes; T Ochsenkühn; P Dirschedl; B Wiebecke; G Paumgartner
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

10.  Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.

Authors:  C Behr; S Ramírez-Hincapié; H J Cameron; V Strauss; T Walk; M Herold; K Beekmann; I M C M Rietjens; B van Ravenzwaay
Journal:  Toxicol Lett       Date:  2018-08-10       Impact factor: 4.372

View more
  2 in total

1.  Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer.

Authors:  Erikka Loftfield; Roni T Falk; Joshua N Sampson; Wen-Yi Huang; Autumn Hullings; Gwen Murphy; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Rashmi Sinha
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

2.  A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer.

Authors:  Zeinab Farhat; Neal D Freedman; Joshua N Sampson; Roni T Falk; Jill Koshiol; Stephanie J Weinstein; Demetrius Albanes; Rashmi Sinha; Erikka Loftfield
Journal:  Hepatol Commun       Date:  2022-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.